Australia's CSL is wielding the axe, cutting its workforce by 15% – around 3,000 positions – while announcing plans to spin its vaccines unit into a standalone company. The decision to demerge the CSL ...

CSL has said that with flu jab rates in the US down between 12% and 14% this year, it has decided to delay the planned spinout of its Seqirus vaccines business and cut its profit forecast for the ...

Donald Trump’s tariffs did not hit the Victorian economy as badly as treasury first feared, but the new taxes still pose a significant risk to the state. Bad deals, nasty numbers, big mistakes and the ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...